Cargando…

HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town

BACKGROUND: In Cape Town, the roll-out of antiretroviral therapy (ART) has increased over the last decade with an estimated coverage of 63% of HIV- positive patients in 2013. The influence of ART on the characteristics of the population of HIV-positive patients presenting to the primary care TB prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Richard, Hermans, Sabine, Caldwell, Judy, Jennings, Karen, Bekker, Linda-Gail, Wood, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069570/
https://www.ncbi.nlm.nih.gov/pubmed/30064368
http://dx.doi.org/10.1186/s12879-018-3256-9
_version_ 1783343523920084992
author Kaplan, Richard
Hermans, Sabine
Caldwell, Judy
Jennings, Karen
Bekker, Linda-Gail
Wood, Robin
author_facet Kaplan, Richard
Hermans, Sabine
Caldwell, Judy
Jennings, Karen
Bekker, Linda-Gail
Wood, Robin
author_sort Kaplan, Richard
collection PubMed
description BACKGROUND: In Cape Town, the roll-out of antiretroviral therapy (ART) has increased over the last decade with an estimated coverage of 63% of HIV- positive patients in 2013. The influence of ART on the characteristics of the population of HIV-positive patients presenting to the primary care TB programme is unknown. In this study, we examined trends in CD4 count distribution, ART usage and treatment outcomes among HIV-positive TB patients in Cape Town from 2009 to 2013. METHODS: Data from the electronic TB register on all newly registered drug-sensitive TB patients ≥18 years were analyzed retrospectively. Descriptive statistics were used to compare baseline characteristics, the CD4 count distribution and TB treatment outcomes both by year of treatment and ART status at the start of TB treatment. Survival analyses were used to assess the change in mortality risk during TB treatment over time, stratified by ART status at start of TB treatment. RESULTS: 118,989 patients were treated over 5 years. HIV prevalence among TB patients decreased from 50.9% in 2009 to 49.0% in 2013. The absolute number of HIV-positive TB cases declined by 13.2% between 2010 and 2013. More patients entered the TB programme on ART in 2013 compared to 2009 (30.0% vs 9.9%). Among these, the CD4 count distribution showed a year by year shift to higher CD4 counts. In 2013, over 75% of ART-naïve TB patients still had a CD4 count < 350 cells/mm(3). ART initiation among ART-naive patients increased from 37.0 to 77.7% and TB case fatality declined from 7.4 to 5.2% (p < 0.001). In multivariate analysis a decrease in TB mortality was most strongly associated with CD4 count (Adjusted HR 0.82 per increase of 50 cells/mm(3), 95% CI: 0.81–0.83, p < 001) and the initiation of ART during TB treatment (Adjusted HR 0.39, 95% CI: 0.35–0.42, p < 0.001). CONCLUSION: Comprehensive changes in the ART and TB treatment programmes resulted in incremental increases in ART coverage for HIV-positive TB patients and a subsequent decrease in TB case fatality due to increased ART uptake in HIV-positive ART-naïve patients. However TB still remained a major presenting opportunistic infection with the majority of cases occurring at low CD4 counts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3256-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6069570
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60695702018-08-03 HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town Kaplan, Richard Hermans, Sabine Caldwell, Judy Jennings, Karen Bekker, Linda-Gail Wood, Robin BMC Infect Dis Research Article BACKGROUND: In Cape Town, the roll-out of antiretroviral therapy (ART) has increased over the last decade with an estimated coverage of 63% of HIV- positive patients in 2013. The influence of ART on the characteristics of the population of HIV-positive patients presenting to the primary care TB programme is unknown. In this study, we examined trends in CD4 count distribution, ART usage and treatment outcomes among HIV-positive TB patients in Cape Town from 2009 to 2013. METHODS: Data from the electronic TB register on all newly registered drug-sensitive TB patients ≥18 years were analyzed retrospectively. Descriptive statistics were used to compare baseline characteristics, the CD4 count distribution and TB treatment outcomes both by year of treatment and ART status at the start of TB treatment. Survival analyses were used to assess the change in mortality risk during TB treatment over time, stratified by ART status at start of TB treatment. RESULTS: 118,989 patients were treated over 5 years. HIV prevalence among TB patients decreased from 50.9% in 2009 to 49.0% in 2013. The absolute number of HIV-positive TB cases declined by 13.2% between 2010 and 2013. More patients entered the TB programme on ART in 2013 compared to 2009 (30.0% vs 9.9%). Among these, the CD4 count distribution showed a year by year shift to higher CD4 counts. In 2013, over 75% of ART-naïve TB patients still had a CD4 count < 350 cells/mm(3). ART initiation among ART-naive patients increased from 37.0 to 77.7% and TB case fatality declined from 7.4 to 5.2% (p < 0.001). In multivariate analysis a decrease in TB mortality was most strongly associated with CD4 count (Adjusted HR 0.82 per increase of 50 cells/mm(3), 95% CI: 0.81–0.83, p < 001) and the initiation of ART during TB treatment (Adjusted HR 0.39, 95% CI: 0.35–0.42, p < 0.001). CONCLUSION: Comprehensive changes in the ART and TB treatment programmes resulted in incremental increases in ART coverage for HIV-positive TB patients and a subsequent decrease in TB case fatality due to increased ART uptake in HIV-positive ART-naïve patients. However TB still remained a major presenting opportunistic infection with the majority of cases occurring at low CD4 counts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3256-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-31 /pmc/articles/PMC6069570/ /pubmed/30064368 http://dx.doi.org/10.1186/s12879-018-3256-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kaplan, Richard
Hermans, Sabine
Caldwell, Judy
Jennings, Karen
Bekker, Linda-Gail
Wood, Robin
HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
title HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
title_full HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
title_fullStr HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
title_full_unstemmed HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
title_short HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
title_sort hiv and tb co-infection in the art era: cd4 count distributions and tb case fatality in cape town
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069570/
https://www.ncbi.nlm.nih.gov/pubmed/30064368
http://dx.doi.org/10.1186/s12879-018-3256-9
work_keys_str_mv AT kaplanrichard hivandtbcoinfectioninthearteracd4countdistributionsandtbcasefatalityincapetown
AT hermanssabine hivandtbcoinfectioninthearteracd4countdistributionsandtbcasefatalityincapetown
AT caldwelljudy hivandtbcoinfectioninthearteracd4countdistributionsandtbcasefatalityincapetown
AT jenningskaren hivandtbcoinfectioninthearteracd4countdistributionsandtbcasefatalityincapetown
AT bekkerlindagail hivandtbcoinfectioninthearteracd4countdistributionsandtbcasefatalityincapetown
AT woodrobin hivandtbcoinfectioninthearteracd4countdistributionsandtbcasefatalityincapetown